Cataracts can be surgically removed without implanting an artificial lens, and this was in fact the only option for centuries before intraocular lenses became standard in the 1980s. The result, however, is a condition called aphakia, where the eye lacks any focusing power of its own and requires thick corrective glasses or contact lenses to see clearly. Today, virtually every cataract surgery includes an artificial lens implant because the visual outcomes are dramatically better. The more interesting version of this question, and the one drawing serious research attention, is whether cataracts can be dissolved, reversed, or the natural lens regenerated so that no artificial replacement is needed at all. That work is genuinely underway, but none of it is ready for routine clinical use.
What Happens When the Lens Is Removed but Not Replaced
The natural lens of the eye contributes roughly a third of the eye’s total focusing power. Remove it and you are left with an extremely farsighted eye, unable to focus on anything at any distance without external correction. This is aphakia, and while it is manageable, the correction options are cumbersome. Thick “coke-bottle” glasses can restore usable vision, but they distort peripheral vision and magnify images unevenly. Contact lenses work better optically, but demand daily care and carry infection risk, which is a particularly serious concern for young children and elderly patients.
In adults, aphakia after cataract surgery is now exceedingly rare by choice. Almost everyone receives an intraocular lens (IOL) at the time of surgery. There are specific situations where a lens cannot be implanted, such as severe eye trauma, certain infections, or anatomical problems that prevent the IOL from sitting stably. In those cases, a secondary IOL can often be placed later once the eye has healed.
The situation is different in children. A young child’s eye is still growing, so the ideal lens power changes year to year. Implanting a fixed-power IOL in an infant means the prescription will be wrong within a few years. Additionally, children’s eyes have a much more aggressive healing response that leads to higher complication rates. For these reasons, some pediatric ophthalmologists choose to leave very young children aphakic temporarily, correcting their vision with contact lenses and considering IOL implantation once the eye has matured more. 1PubMed Central. Optical correction of aphakia in children The visual rehabilitation demands constant follow-up, because any blur left uncorrected during the first years of life risks permanent amblyopia, a condition where the brain never learns to use that eye properly.
Why the Natural Lens Clouds in the First Place
Understanding why researchers are trying so hard to find alternatives to surgery requires a quick look at what a cataract actually is. The lens is mostly made of proteins called crystallins, which are arranged in an extraordinarily precise, transparent structure. These proteins are among the longest-lived in the body. Unlike skin or blood cells, the crystallins you are born with are the same ones you carry into old age. Over decades, cumulative damage from UV light, oxidation, and metabolic byproducts causes these proteins to unfold and clump together into insoluble aggregates that scatter light instead of transmitting it.2PubMed Central. Protein misfolding and aggregation in cataract disease and prospects for prevention Once enough aggregation has occurred, the lens turns cloudy and vision deteriorates. The aggregated proteins form solid-like clumps rather than loose, easily reversible clusters, which is part of what makes the damage so difficult to undo.3Scientific Reports. Phase separation of α-crystallin-GFP protein and its implication in cataract disease
Multiple aggregation pathways exist, and they produce clumps with varied structures depending on which specific crystallin proteins are involved and what triggered the damage.4PubMed Central. Function and Aggregation in Structural Eye Lens Crystallins This diversity of mechanisms is one reason why a single drug solution has proven elusive: a compound that works against one type of aggregate may be useless against another.
The Lanosterol Story and Why It Stalled
In 2015, a widely covered study reported that lanosterol, a natural steroid the body already produces, could dissolve cataracts in animal models. The headlines were electric. The reality since then has been more sobering.
When independent labs tested lanosterol on actual human cataract tissue, the results were disappointing. A study using 25 millimolar lanosterol solution on extracted human cataract nuclei found no reversal of opacity after six days of incubation.5PubMed Central. Effect of lanosterol on human cataract nucleus Another research team went further, testing lanosterol in liposome formulations designed to improve penetration into the lens. Not only did lanosterol fail to reverse opacities, but all the treated lenses actually progressed to a more advanced cataract stage during the experiment. The researchers also found that lanosterol did not increase the level of soluble proteins or decrease insoluble proteins in the lens, meaning it simply was not dissolving the aggregates.6Scientific Reports. Failure of Oxysterols Such as Lanosterol to Restore Lens Clarity from Cataracts
Molecular docking studies offered an explanation: lanosterol binds only weakly to the crystallin proteins it would need to interact with to break up aggregates. The binding energy was far too low to suggest any meaningful therapeutic effect at achievable concentrations.6Scientific Reports. Failure of Oxysterols Such as Lanosterol to Restore Lens Clarity from Cataracts
The picture is not entirely negative. One lab study using isolated crystallin aggregates from human cataract tissue did find that lanosterol and a related compound, 25-hydroxycholesterol, could dissociate aggregates in vitro, but the effectiveness depended heavily on cataract severity.7PubMed. Lanosterol and 25-hydroxycholesterol dissociate crystallin aggregates isolated from cataractous human lens via different mechanisms There is also a practical delivery problem: even if a compound could dissolve aggregates in a dish, getting it from the outside of the eye through the cortex of the lens and into the dense inner nucleus where most age-related cataracts form is an enormous barrier.8PubMed Central. Inhibitory effect of lanosterol on cataractous lens of cynomolgus monkeys using a subconjunctival drug release system The lens lacks blood vessels, so drugs cannot hitch a ride through the bloodstream. They have to diffuse through tissue that is specifically designed to be dense and tightly packed.
N-Acetylcarnosine Eye Drops
If you search online for non-surgical cataract treatments, you will quickly encounter N-acetylcarnosine (NAC) eye drops, sold under brand names like Can-C. These are marketed aggressively, with claims that they can reverse or prevent cataracts. A small number of studies, primarily from a single research group that holds patents on the formulation, have reported improvements in visual acuity and glare sensitivity in people using 1% NAC drops.9PubMed. Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops
However, when the Cochrane Collaboration, which specializes in evaluating medical evidence, reviewed the available data on NAC eye drops, the conclusion was blunt: there is currently no convincing evidence that NAC reverses cataract or prevents its progression.10PubMed Central. N‐acetylcarnosine (NAC) drops for age‐related cataract The existing studies suffered from methodological problems, and no large, independent, well-controlled trial has confirmed the claims. That does not mean the drops are harmful, but spending money on them as an alternative to surgery is not supported by current evidence. If your ophthalmologist says you need cataract surgery, NAC drops are not a substitute.
Regenerating a New Lens from the Eye’s Own Stem Cells
Perhaps the most fascinating research in this space is the possibility of growing a new, functional lens after the old one has been removed. This approach has actually been demonstrated in human infants.
The key insight is that the lens capsule, the thin elastic bag that surrounds the natural lens, contains stem cells called lens epithelial cells (LECs). In standard cataract surgery, the surgeon makes a relatively large opening in the front of this capsule, removes the cloudy material, and implants an artificial lens. This process destroys or displaces most of those stem cells. But a team of researchers in China designed a minimally invasive approach that uses a much smaller capsule opening positioned at the edge rather than the center, preserving the bulk of the LECs along with their natural microenvironment.11PubMed Central. Lens regeneration using endogenous stem cells with gain of visual function After the cloudy lens material was removed through this small opening, the remaining stem cells gradually regenerated a transparent, functional lens.
The approach was first validated in rabbits and macaque monkeys, then tested in a small group of human infants with congenital cataracts. The regenerated lenses showed meaningful visual function, and the outcomes were better than those seen with traditional surgery in similar cases.12PubMed Central. Lens regeneration in humans: using regenerative potential for tissue repairing Researchers are now exploring metabolic supplements like nicotinamide to improve the clarity and speed of regeneration.13Current Ophthalmology Reports. Crystalline Lens Regeneration: A Review
There is an important caveat: this has only been shown to work in infants, whose lens stem cells are young and vigorous. In adult eyes, the picture is quite different. The number of functional stem cells in the central zone of the lens appears to drop in people with cataracts, and the cells that remain show reduced regenerative capacity.14Investigative Ophthalmology & Visual Science. Decline in the adult human lens epithelial stem cell function with aging and in cataract Whether an older adult’s stem cells can regrow a clear, optically useful lens remains an open and frankly skeptical question. Some animals, like newts, can regenerate a full lens throughout their lives, but mammals have far less regenerative capacity, and that gap has not been bridged.15PubMed Central. Eye on regeneration
The Problem of Secondary Cataracts
Any approach that leaves the lens capsule intact, whether for stem cell regeneration, hydrogel refilling, or preservation of the natural lens, faces a common adversary: posterior capsule opacification (PCO), often called a “secondary cataract.” After cataract surgery, residual lens epithelial cells left on the inside of the capsular bag tend to proliferate and migrate across the back surface of the capsule. Some of these cells undergo a transformation that produces fibrous tissue, creating folds and wrinkles that blur vision. Others regenerate crystallin-expressing fibers that form opaque pearl-like clusters.16JAMA Ophthalmology. Posterior Capsular Opacification: A Problem Reduced but Not Yet Eradicated
PCO currently affects a meaningful percentage of patients after standard cataract surgery, though modern IOL designs have reduced the rate substantially. It is easily treated with a quick laser procedure that creates an opening in the clouded posterior capsule. But for regenerative approaches that depend on those same epithelial cells to regrow a lens, PCO is a paradox: the cells you need alive for regeneration are the same cells that cause opacification. Controlling one without sabotaging the other is one of the hardest problems in this field.
Hydrogel Lens Refilling
Another alternative under investigation is removing the cataractous lens contents while keeping the capsular bag intact, then injecting a synthetic hydrogel that mimics the optical and mechanical properties of a young, natural lens. The idea has been around for over two decades. Early experiments showed that copolymeric hydrogels could be injected into an emptied lens capsule and would gel rapidly into an optically clear material.17PubMed. Refilling of ocular lens capsule with copolymeric hydrogel containing reversible disulfide
Recent work has advanced the concept considerably. A 2025 study described a multifunctional injectable hydrogel that uses layered crosslinking to create a gradient refractive index, something closer to how a real lens bends light across its structure. In a rabbit model, this hydrogel lens provided effective refractive correction and also suppressed postoperative complications including the inflammatory response that typically follows surgery.18PubMed. Multifunctional Injectable Hydrogel as a Biomimic Lens: Optical-Mechanical Restoration and Dynamic Postoperative Microenvironment Regulation If a gel lens could also flex in response to the eye’s focusing muscles, it might restore some degree of accommodation, the ability to shift focus between near and far that all artificial IOLs still struggle to replicate well.
The approach is still confined to animal studies and has not been tested in human eyes. Maintaining long-term optical clarity, preventing the gel from clouding or shrinking over years, and solving the PCO problem inside the capsule are all unresolved challenges.
Femtosecond Laser Approaches
Femtosecond lasers are already used in some cataract surgeries to make precision cuts in the cornea and lens capsule. But a separate line of research is exploring whether these ultrafast lasers can treat the lens without removing it at all. The idea is called femtosecond lentotomy: by creating tiny gliding planes inside the lens using focused laser pulses, the stiffened lens tissue can be made more flexible, potentially restoring some ability to change shape and focus.
Experiments on pig lenses showed that creating a series of patterned cuts inside the lens reduced its stiffness measurably, from about 37 to about 31 kilopascals in one protocol.19PubMed Central. Quantitative fs-laser crystalline lens softening surgery towards presbyopia treatment based on optical coherence elastography This work is primarily aimed at presbyopia, the age-related loss of near focusing ability that affects everyone past about age 45, rather than at cataracts specifically.20Investigative Ophthalmology & Visual Science. Improving Presbyopic Eye Accommodative Response by Softening Mid-Periphery of the Crystalline Lens via Ultra-Fast Laser But the two conditions are related, since the same age-related protein changes that stiffen the lens also contribute to clouding. If laser softening can preserve the natural lens in a functional state for longer, it might delay or reduce the need for cataract surgery in some people.
Gene Therapy and Small-Molecule Chaperones
Looking further ahead, researchers are exploring whether the underlying genetic and molecular causes of cataracts can be targeted directly. For congenital cataracts caused by specific gene mutations, gene therapy that corrects or compensates for the defective gene could theoretically prevent lens clouding from developing at all.21Quality in Sport. The Genetic Basis of Congenital Cataracts: Advances in Diagnostics and Therapeutics This remains early-stage, and delivering gene therapy to the lens, which is avascular and enclosed in its capsule, poses similar drug delivery challenges as every other non-surgical approach.
Small-molecule chaperones represent another avenue. The idea is to find compounds that can stabilize crystallin proteins in their properly folded state, preventing the misfolding and aggregation that causes cataracts. Antioxidant compounds, aldose reductase inhibitors (which target a sugar metabolism pathway implicated in diabetic cataracts), and direct aggregation inhibitors are all being studied. While experimental results have been encouraging in lab settings, none have yet demonstrated clinical efficacy in human trials with the kind of rigor that would change practice.2PubMed Central. Protein misfolding and aggregation in cataract disease and prospects for prevention Optimizing how these drugs actually reach the interior of the lens remains a fundamental obstacle.
Why Surgery Remains the Standard
Modern cataract surgery is one of the most commonly performed and successful operations in all of medicine. The procedure takes roughly 15 to 20 minutes, typically uses only topical anesthesia, and most people notice dramatically improved vision within days. Femtosecond laser-assisted surgery has refined the precision of certain steps, producing more centered and circular capsule openings that can reduce optical aberrations compared to manual techniques.22PubMed Central. Comparative visual outcomes of EDOF intraocular lens with FLACS vs conventional phacoemulsification Premium IOLs can now correct astigmatism, provide extended depth of focus, and reduce dependence on glasses for many tasks.
None of the non-surgical alternatives described above can yet match these outcomes. The pharmacological approaches have not been proven to work in living human eyes. Stem cell regeneration has only been achieved in infants. Hydrogel refilling has only been tested in animals. Laser softening addresses presbyopia more than cataracts. Each of these fields is advancing, and it is plausible that within a generation some of them will produce viable treatments, particularly for early-stage cataracts or for populations where surgery is difficult to access. Hundreds of millions of people worldwide live with untreated cataracts because they lack access to operating rooms, trained surgeons, or affordable IOLs. A proven eye drop that could delay cataract progression by even five to ten years would be transformative for global eye health, even if it never eliminated the need for surgery entirely.
What Patients Actually Want to Know
If you have been diagnosed with cataracts and are searching for alternatives to surgery, the honest answer today is that no proven alternative exists. Eye drops and supplements marketed as cataract treatments are not supported by independent evidence. Delaying surgery is perfectly reasonable if your cataracts are not yet interfering with daily life, since there is no medical urgency to operate on a cataract that is not causing problems. But once cataracts impair your ability to drive, read, or do the things that matter to you, surgery with an IOL implant is the only treatment with a strong evidence base.
If you are a parent of a child with congenital cataracts, it is worth asking your pediatric ophthalmologist about minimally invasive techniques that preserve lens epithelial cells, since this is the one area where regenerative approaches have shown real results in humans. The availability of these techniques varies by center and by country, and they are not yet standard of care everywhere, but the early results are genuinely promising. For everyone else, the most productive thing you can do is protect your eyes from UV exposure, manage diabetes and other systemic conditions that accelerate lens damage, and get regular eye exams so that when cataracts do develop, they can be addressed before they become advanced enough to complicate surgery.